A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of IBI112 in Patients With Moderate to Severe Active Ulcerative Colitis A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Clinical Study to Eva ...